These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2996690)

  • 1. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
    Johansson R; Kilkku P; Groenroos M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
    [No Abstract]   [Full Text] [Related]  

  • 3. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
    Einhorn LH; Nagy C; Furnas B; Williams SD
    J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Einhorn L
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
    [No Abstract]   [Full Text] [Related]  

  • 5. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
    Chan HS; Correia JA; MacLeod SM
    Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
    Wada JK; Bogdon DL; Gunnell JC; Hum GJ; Gota CH; Rieth TE
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():39-44. PubMed ID: 6299554
    [No Abstract]   [Full Text] [Related]  

  • 7. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Levitt M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
    [No Abstract]   [Full Text] [Related]  

  • 8. Study design for the evaluation of the efficacy and safety of nabilone.
    Stark P
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():35-7. PubMed ID: 6299553
    [No Abstract]   [Full Text] [Related]  

  • 9. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
    Niiranen A; Mattson K
    Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
    Orr LE; McKernan JF
    J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
    Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
    J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
    Jones SE; Durant JR; Greco FA; Robertone A
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    Ahmedzai S; Carlyle DL; Calder IT; Moran F
    Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
    Lane M; Smith FE; Sullivan RA; Plasse TF
    Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting.
    Cone LA; Greene DS; Helm NA
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():63-70. PubMed ID: 6299558
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
    Pomeroy M; Fennelly JJ; Towers M
    Cancer Chemother Pharmacol; 1986; 17(3):285-8. PubMed ID: 3017596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
    Orr LE; McKernan JF; Bloome B
    Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
    Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
    N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
    Steele N; Gralla RJ; Braun DW; Young CW
    Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.